Trial
NCT04572243
A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Eisai Inc.
Collaborators
—
Condition
Epilepsies, Myoclonic
Intervention
Placebo
Why stopped
The study was terminated by Sponsor and the decision was not due to any safety or efficacy reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-08